Federal Register #CMS-3367-FC

CMS Final Rule: Oversight and Conflict-of-Interest Standards for Medicare Accrediting Organizations

This final rule from the Centers for Medicare & Medicaid Services (CMS) focuses on regulatory oversight of Medicare accrediting organizations (AOs): - Government Buyer: - Department of Health and Human Services, Centers for Medicare & Medicaid Services (CMS), Quality, Safety & Oversight Group - No Original Equipment Manufacturers (OEMs) or commercial vendors are involved, as this is a regulatory action - Key Provisions: - Requires AOs to use Medicare conditions as minimum accreditation standards - Prohibits conflicts of interest among AO owners, surveyors, and employees - Restricts AOs from providing fee-based consulting services to the same providers they accredit - Mandates unannounced surveys and enhances comparability with State agency survey processes - Implements direct observation validation surveys to monitor AO performance - Limits re-entry of terminated providers into Medicare, requiring State oversight before re-approval - Notable Requirements: - AOs must submit applications and renewals every 4 to 6 years - Ongoing compliance monitoring and validation surveys - Technical corrections for End-Stage Renal Disease facilities and Transplant Programs - No procurement of products or services is requested; the rule is focused on regulatory standards, transparency, and conflict-of-interest prevention

Description

This final rule with comment period sets forth provisions to strengthen the oversight of Medicare national accrediting organizations by addressing conflicts of interest, establishing consistent standards, processes, and definitions, and updating the validation and performance standards systems. It revises the psychiatric hospital survey process, adds limitations on terminated deemed providers and suppliers when reentering the program, and provides technical corrections for End-Stage Renal Disease facilities and Transplant Programs. The rule aims to ensure unbiased, consistent accreditation and improve patient care quality. The regulations are effective June 16, 2027.

View original listing